Anna C. Figueiredo

Dermatology

9305 W Thomas Rd Ste 305
Phoenix, AZ 85037

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program.

Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program.

Journal: Journal of the American Academy of Dermatology

Published: September 13, 2019

Showing 1-1 of 1

Last Updated: 09/26/2026